Article
Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1.
Scientific reports - 31 Jan 2024
Liang Xiaoxiao, Shi Haiyan, Bi Kehong, Feng Saran, Chen Shixian, Zhao Wei, Huang Xin
Abstract excerpt
Affected by differences in the pharmacokinetics (PK) of lenalidomide, the toxicity of lenalidomide varies among different patients, with serious toxicity leading to dose reduction or discontinuation. The differences in the PK of lenalidomide may be related to factors such as patients' physiological characteristics, pathological characteristics and gene polymorphisms etc., which may also affect its toxicity. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
